Education
About Us
Working with TipRanks
Follow Us
Active Biotech AB (SE:ACTI)
:ACTI
Laquinimod
Eye Diseases
Phase I
Completed
A Study of Laquinimod Eye-drops in Healthy Participants
Dec 06, 2021
―
Tasquinimod
Prostate Cancer
Phase III
Completed
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Nov 01, 2010
―
Abr-215050, Tasquinimod
Prostate Cancer
Phase II
Completed
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Nov 15, 2007
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Active Biotech AB (ACTI) have in its pipeline
ACTI is currently developing the following drugs: Laquinimod, Tasquinimod, Abr-215050, Tasquinimod. These drug candidates are in various stages of clinical development as the company works toward FDA approval.